title: Malignancies in inflammatory bowel disease.
abstract: Patients with inflammatory bowel diseases (IBDs) are at increased risk of colorectal cancer (CRC), but the risk varies between different studies and seems to be decreasing. The cumulative risk of CRC has been reported to be 1%, 2%, and 5% after 10, 20, and over 20 years of disease duration, respectively, in recent meta-analysis. Disease duration and grade of inflammation are the main driving forces of dysplasia and CRC development. Also, the risk of extraintestinal cancers is increased in IBD, where the degree of immunosuppression and its duration are the most important risk factors. Most important extraintestinal malignancies are lymphomas and non-melanoma skin cancers, both of which are increased in patients receiving thiopurines. Also, extraintestinal manifestations or concomitant diseases such as primary sclerosing cholangitis predispose IBD patients to malignancies such as cholangiocarcinoma. History of previous cancer increases the risk of developing either new or recurrent cancers and should be taken into account when choosing therapy and planning surveillance. Dysplasia and cancer screening and surveillance must be individualized according to patients' risk factors. Malignancies are the second most common cause of death after cardiovascular diseases in both genders in patients with IBD.
authors.affiliation: Helsinki University Hospital, Department of Medicine, Division of Gastroenterology , Helsinki , Finland.
authors.forename: Urpo
authors.initials: U
authors.lastname: Nieminen
authors.forename: Martti
authors.initials: M
authors.lastname: Färkkilä
mesh_terms: D015179:Colorectal Neoplasms / Q000175:diagnosis / Q000209:etiology / Q000401:mortality; D055088:Early Detection of Cancer; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D015212:Inflammatory Bowel Diseases / Q000150:complications* / Q000188:drug therapy; D009369:Neoplasms / Q000175:diagnosis / Q000209:etiology* / Q000401:mortality; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D007166:Immunosuppressive Agents
keywords: colorectal cancer; extraintestinal malignancies; inflammatory bowel disease; malignancy